中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
34期
106-107
,共2页
氟伐他汀缓释片%氯吡格雷%联合%不稳定型心绞痛
氟伐他汀緩釋片%氯吡格雷%聯閤%不穩定型心絞痛
불벌타정완석편%록필격뢰%연합%불은정형심교통
Fluvastatin-clopidogrel%Unstable%Combined%Angina pectoris
目的:观察氟伐他汀缓释片联合氯吡格雷治疗不稳定型心绞痛(UAP)的疗效。方法:选择2010年4月-2012年12月本院治疗的UAP患者58例,按随机数字表法分为治疗组和对照组各29例。对照组给予常规治疗,治疗组在常规治疗的基础上再给予氟伐他汀缓释片联合氯吡格雷治疗,两组均治疗4周。比较两组患者治疗前后血清总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、高敏C反应蛋白(hs-CRP)等指标;观察两组临床疗效及不良反应。结果:两组治疗后TC、TG、LDL-C、HDL-C、hs-CRP均优于治疗前(P<0.05),且治疗组治疗后均优于对照组(P<0.05);治疗组总有效率93.10%优于对照组68.97%(P<0.05);两组均无明显不良反应。结论:氟伐他汀缓释片联合氟吡格雷治疗UAP疗效确切,能显著改善患者临床指标,安全可靠,值得推广应用。
目的:觀察氟伐他汀緩釋片聯閤氯吡格雷治療不穩定型心絞痛(UAP)的療效。方法:選擇2010年4月-2012年12月本院治療的UAP患者58例,按隨機數字錶法分為治療組和對照組各29例。對照組給予常規治療,治療組在常規治療的基礎上再給予氟伐他汀緩釋片聯閤氯吡格雷治療,兩組均治療4週。比較兩組患者治療前後血清總膽固醇(TC)、甘油三脂(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、高敏C反應蛋白(hs-CRP)等指標;觀察兩組臨床療效及不良反應。結果:兩組治療後TC、TG、LDL-C、HDL-C、hs-CRP均優于治療前(P<0.05),且治療組治療後均優于對照組(P<0.05);治療組總有效率93.10%優于對照組68.97%(P<0.05);兩組均無明顯不良反應。結論:氟伐他汀緩釋片聯閤氟吡格雷治療UAP療效確切,能顯著改善患者臨床指標,安全可靠,值得推廣應用。
목적:관찰불벌타정완석편연합록필격뢰치료불은정형심교통(UAP)적료효。방법:선택2010년4월-2012년12월본원치료적UAP환자58례,안수궤수자표법분위치료조화대조조각29례。대조조급여상규치료,치료조재상규치료적기출상재급여불벌타정완석편연합록필격뢰치료,량조균치료4주。비교량조환자치료전후혈청총담고순(TC)、감유삼지(TG)、저밀도지단백(LDL-C)、고밀도지단백(HDL-C)、고민C반응단백(hs-CRP)등지표;관찰량조림상료효급불량반응。결과:량조치료후TC、TG、LDL-C、HDL-C、hs-CRP균우우치료전(P<0.05),차치료조치료후균우우대조조(P<0.05);치료조총유효솔93.10%우우대조조68.97%(P<0.05);량조균무명현불량반응。결론:불벌타정완석편연합불필격뢰치료UAP료효학절,능현저개선환자림상지표,안전가고,치득추엄응용。
Objective:To observe the therapeutic effects of combined fluvastatin-clopidogrel treatment on unstable angina pectoris(UAP). Method:58 patients with UAP treated in our hospital from April 2010 to December 2012 were selected and randomly divided into control group and treatment group according to random number table method,each had 29 patients. Conventional treatment was given in the control group,while fluvastatin sustained-release tablets combined with clopidogrel was used in the treatment group on the basis of conventional treatment for four weeks. Compared the index of serum total cholesterol(TC),triglycerides(TG),low-density lipoprotein(LDL-C),high-density lipoprotein(HDL-C),high-sensitivity C-reactive protein(hs-CRP)between two groups. Observed their clinical effects and side effect. Result:After treatment,all the index of TC,TG, LDL-C,HDL-C and hs-CRP were better in both of groups(P<0.05),while the index of TC,TG,LDL-C,HDL-C and hs-CRP of treatment group were better than those of control group(P<0.05). The clinical total effective rate of the treatment group was 93.10%,which was better than 68.97%of control group(P<0.05). There were no side effects in both of groups. Conclusion:Fluvastatin sustained-release tablets combined with clopidogrel shows efficacy on treating UAP,significantly improve the clinic index of patients. Thus,the treatment method is safe and reliable,and worth to popularize.